US Broker Ratings

GSK plc (GSK) Stock Report: Exploring a Healthcare Giant with a 10.81% Potential Upside

GSK plc (NYSE: GSK), a cornerstone in the healthcare sector, offers investors a promising opportunity with a potential upside of 10.81%, according to analyst projections. With..

DexCom, Inc. (DXCM) Investor Outlook: Navigating the Healthcare Sector with Promising Growth Potential

DexCom, Inc. (NASDAQ: DXCM) stands as a leading innovator in the healthcare sector, particularly within the medical devices industry. Specializing in continuous glucose monitoring (CGM) systems,..

Humana Inc. (HUM) Stock Analysis: Evaluating Growth Potential with a 9.91% Upside

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, has captured the attention of investors with its robust performance and strategic positioning within the..

CVS Health Corporation (CVS) Stock Analysis: 24.79% Potential Upside Piques Investor Interest

Investors in CVS Health Corporation (NYSE: CVS) are eyeing a substantial potential upside of 24.79%, as indicated by the average target price of $116.08 set by..

Gilead Sciences, Inc. (GILD) Stock Analysis: Unpacking the Upside Potential Amidst a 7.72% Forecasted Growth

Gilead Sciences, Inc. (NASDAQ: GILD) has long been a pivotal player in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization..

Insulet Corporation (PODD) Stock Analysis: Unpacking a Strong 16% Upside Potential

Insulet Corporation (NASDAQ: PODD), a prominent player in the medical devices industry, specializes in insulin delivery systems, gaining substantial attention from investors with its innovative Omnipod..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling the 24.46% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, specifically within the medical devices industry, is catching the eye of investors with a..

Merck & Company, Inc. (MRK) Stock Analysis: Navigating a Potential -3.13% Downside Despite Robust Buy Ratings

Merck & Company, Inc. (MRK), a stalwart in the healthcare sector, continues to stand out among drug manufacturers with a commanding market capitalization of $376.37 billion...

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 29% Potential Upside Amidst Market Volatility

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, presents an intriguing investment opportunity for those willing to navigate its current market fluctuations. With..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Its 6.53% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is making waves in the healthcare sector, particularly the medical devices industry. With a market capitalization of $19.26 billion, the..

Waters Corporation (WAT) Stock Analysis: Revenue Growth Soars Over 113% Amid Strategic Expansion

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 17% Upside Potential in the Healthcare Sector

Investors looking for opportunities in the healthcare sector would do well to consider Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the medical devices industry...

Mettler-Toledo International, Inc. (MTD): Stock Analysis Reveals 5.28% Potential Upside in Diagnostics & Research Sector

For investors looking to delve into the healthcare sector, Mettler-Toledo International, Inc. (NYSE: MTD) represents a compelling opportunity within the diagnostics and research industry. Headquartered in..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 21.82% Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, continues to capture investor attention with its robust market position and promising growth prospects. With..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a 16% Upside Potential

Cencora, Inc. (NYSE: COR), a major player in the healthcare sector, has captured the attention of investors with its strategic positioning in the medical distribution industry...

Bristol-Myers Squibb (BMY) Investor Outlook: Navigating Healthcare Growth Amidst Mixed Ratings

Bristol-Myers Squibb Company (NYSE: BMY) stands as a significant player in the healthcare sector, specifically within the general drug manufacturing industry. With a robust market capitalization..

Eli Lilly (LLY) Investor Outlook: Navigating Growth and Strong Analyst Ratings in the Healthcare Sector

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to capture investor attention with its robust growth trajectory and favorable analyst ratings...

Vertex Pharmaceuticals (VRTX) Stock Analysis: Strong Revenue Growth and Promising Drug Pipeline Propel Investor Interest

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading biotechnology company based in Boston, continues to capture investor attention with its robust market position and innovative pharmaceutical developments...

Elevance Health, Inc. (ELV) Stock Analysis: Riding a 12.12% Potential Upside with Strong Analyst Support

Elevance Health, Inc. (NYSE: ELV) stands as a formidable entity in the healthcare plans sector, boasting a substantial market capitalization of $86.86 billion. This Indianapolis-based company,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds